Client Alerts & Insights
Benesch COVID-19 Resource Center: Recovery Rebates Not Countable for Public Assistance Purposes
March 31, 2020
Authored By:
As has been widely publicized, the CARE Act includes a provision for one time payments, referred to as “recovery rebates”, of up to $1200 for some taxpayers and certain non-taxpayers. The amounts will vary depending upon marital status, number of children and annual income as determined by either a taxpayer’s 2018 or 2019 Adjusted Gross Income (AGI) as found on the taxpayer’s tax return. Persons who have not filed a tax return for either of those years and who are otherwise eligible may file a return to qualify. Recipients of these payments who are also recipients of, or applicants for, federally funded public assistance benefits such as Medicaid and SNAP ( Supplemental Nutrition Assistance Program) can receive these payments without fear of losing eligibility for their public assistance benefits. These rebate payments do not count as income or resources for a 12-month period in determining eligibility for, or the amount of assistance provided by, any federally funded public benefit program. In addition, these payments are not taxable. This is good news for the those on Medicaid benefits and for their providers.
For further information about the rebates and who qualifies, see the Congressional Research Service Report here.
If you have any questions regarding the content above, please contact a member of your Benesch team.
Martha J. Sweterlitsch at msweterlitsch@beneschlaw.com or 614.223.9367.
Jessica N. Angney at jangney@beneschlaw.com or 216.363.4620.
***
Please note that this information is current as of the date of this client bulletin, based on the available data. However, because COVID-19’s status and updates related to the same are ongoing, we recommend real-time review of guidance distributed by CDC and local officials.

Latest News
FTC Enforcement Trends in 2026: What Businesses, Advertisers Should Be Watching Now
Regulators continue to signal a return to core consumer‑friendly principles through new rulemaking initiatives, and recent enforcement activity, warning letters, and public commentary offer a practical preview of where scrutiny is likely to concentrate in 2026…
IEEPA Tariffs – Top Five Q&A for Supply Chains after U.S. Supreme Court Decision
The U.S. Supreme Court issued its highly anticipated decision regarding tariffs Friday. The Court held that the International Emergency Economic Powers Act (“IEEPA”) does not authorize the President to impose tariffs according to the 6-3 decision…
Watch Your T&Cs! When Done Right, Terms and Conditions are Both Viable—And Valuable
The era of the paper/hard copy bill of lading and/or rate confirmation is fading fast. Hard copies and paper do live on in various shipment schematics; however, increasingly, and at a very rapid rate, transactions between shippers, carriers, brokers and forwarders are conducted by, and memorialized in, electronic form via email, interactive website access and response, and—more and more—AI mechanisms.
The Long Tail of the Opioid Crisis: How AGs Continue to Pursue Manufacturers, Distributors, Pharmacies
The opioid crisis has been a perennial priority for state attorneys general, and was the marquis priority for the National Association of Attorneys General (NAAG) in both 2023 (under OH AG Dave Yost) and 2025 (under NH AG John Formella). Recently, Texas Attorney General Ken Paxton announced the conclusion of a multistate effort to secure the bankruptcy reorganization plan for Purdue Pharma (Purdue).